Our focus is to develop a diverse cadre of clinicians who are adept at prevention, screening, diagnosis and treatment of a broad range of malignancies, as well as benign hematologic diseases. This is a three-year program involving comprehensive clinical training in both medical oncology and hematology, satisfying double-board eligibility, with protected time to pursue an original research project. Fellows are trained in all procedures relating to oncology/hematology, including bone marrow aspiration, biopsy and interpretation, coagulation testing, blood banking, chemotherapy administration and stem cell transplantation. The Division is a member of the Southwest Oncology Group and is a site for numerous investigational drug and treatment trials in hematologic, as well as malignant disease. Fellows and their faculty mentor develop an individualized development plan to foster their research and clinical subspecialty goals.
Marc Braunstein, MD, PhD
Program Director, Oncology / Hematology Fellowship Program
NYU Winthrop Hospital is a 591-bed university-affiliated medical center which proudly offers sophisticated diagnostic and therapeutic care in virtually every specialty and subspecialty of medicine and surgery. We are a major regional healthcare resource with a deep commitment to medical education and research, offering a full complement of inpatient and outpatient services. We are also Nassau County’s only American College of Surgeons certified adult Level 1 Trauma Center with full adult and pediatric capabilities.
Rest assured that whatever medical care you or your family may need, NYU Winthrop is committed to a profound guiding principle: “Your Health Means Everything”
NYU Winthrop Hospital has been a focal point of academic medicine on Long Island and is now very proud to partner with the NYU Long Island School of Medicine, a newly LCME accredited, innovative 3-year medical school located on the hospital campus with a mission to educate exemplary physicians and academic leaders in primary care. In addition, we sponsor over 30 medical and surgical residency and fellowship training programs where 300 physicians have chosen to pursue their post-graduate medical education.
NYU Winthrop has a vibrant multi-faceted research program. As part of its mission as a teaching hospital, NYU Winthrop physicians and scientists are engaged in groundbreaking basic and clinical biomedical research.
Ever changing and growing with the diverse community it serves, NYU Winthrop Hospital is, in many ways, a unique institution, simultaneously large and small, regional as well as local. We successfully blend the progressive philosophy, sophistication and advances of a teaching and research institution with a very personal approach to patient care – an approach that has become the cornerstone of our organization.
During the first two years of training, the fellowship program emphasize clinical training in Oncology and Hematology in six-month alternating blocks. Fellows perform consults daily on inpatient medical and surgical services, and have a major responsibility for the weekly outpatient Oncology/Hematology Teaching Practice. During the second year, fellows assume a leadership role in teaching and rounding on the inpatient services with Internal Medicine residents and first year fellows. During the third year, there is sustained scholarly activity, as well as continued outpatient experience. Third year fellows continue in a leadership role, overseeing junior fellows during continued outpatient experiences and have the opportunity to explore special interests via electives in Pediatric Oncology, Gynecologic Oncology, Tumor Pathology, Cytogenetics, and Molecular Methods. All PGY fellows (4,5,6) are involved in subspecialized clinics with faculty. Fellows also dedicate time to scholarly and research activities/publishing. Didactic conferences in both hematology and oncology are provided throughout the three years of fellowship training.
|Bone Marrow Transplant||1|
Seven full-time attending physicians, all double-boarded in Hematology and Medical Oncology
Full array of tertiary services to support complex treatment protocols including robotic surgery, infectious disease, rehabilitation, radiopharmaceuticals, advanced endoscopy, cyberknife radiosurgery, and genetics counseling. A new 32-chair state-of-the-art infusion center and a dedicated inpatient unit for ambulatory and inpatient treatments. Access to a wide variety of pathology, including more than 2000 cases annually, treatments including intensity modulated radiation therapy, monoclonal antibody based therapy, and autologous stem cell transplantation.
Research: We have a new generation of investigational trials using newer targeted agents. NYU Winthrop participates in numerous cancer clinical trials and faculty interests include epidemiology of colon cancer as well as tumor marker validation in breast and lung cancers.
Marc J. Braunstein, MD, PhD
Assistant Professor Medicine
Program Director, Hematology Oncology Fellowship
Jeffrey Schneider, MD
Chief, Oncology Hematology Division
Director, Thoracic Lung Cancer Program
Associate Professor of Medicine
Alexander Hindenburg, MD
Assistant Chief, Oncology Hematology Division
Associate Professor of Medicine
Michael Garrison, MD
Assistant Professor of Medicine
Nina D’Abreo, MD
Assistant Professor of Medicine
Mary O’Keeffe, MD
Assistant Professor of Medicine
Douglas Marks, MD
Assistant Professor of Medicine
Jaime Andres Suarez-Londono, MD
Assistant Professor of Medicine
Assistant Program Director, Oncology Hematology Fellowship
Robert Weiner, MD
Assistant Professor of Medicine
Marissa Rybstein, MD
Assistant Professor of Medicine
Ready N, Farago AF, de Braud F, Atmaca A, Hellmann MD, Schneider JG, Spigel DR, Moreno V, Chau I, Hann CL, Eder JP, Steele NL, Pieters A, Fairchild J, Antonia SJ, Third-Line Nivolumab Monotherapy in Recurrent SCLS: CheckMate 032. J Thorac Oncol 2019 Feb; 14(2) 237-244, PMID 30316010
Rybstein, Marissa, DeSancho MT: Risk Factors and Clinical Management of venous thromboembolism during pregnancy. PMID 31449506. Weill Cornell NY Presbyterian
D’Abreo N, Adams S: Immune Checkpoint Inhibition for Metastatic triple-negative breast cancer: safety first ? Nat Rev Clin Oncol. 2019 July. 16(7) 399-400. PMID 31053774
Braunstein M, Muddasani R, Mobolaji O, Kennedy Snodgrass, Barnea Slonim L: Hemophagocytic Lymphohistiocytosis Secondary to Babesia in an Immunocompetent Adult. Accepted for publication in the American Journal of Hematology. 2019 March; 94(3) 379-383 PMID 30478854
Long GV, Tykodi SS, Schneider JG, Garbe C, Gravis G, Rashford M, Agarwal S, Bello A, Grigoryeva E, Roy A, Rollin L, Zhao X. Assessment of Nivolumab exposure and clinical safety of 480 mg q. 4 weeks flat dosing schedule in patients with cancer. Annals of Oncology 0: 1-6. 2018. 1093/annonc/mdy408
Schneider JG, Ready AN, Farago AF, deBraud F, Atmaca A, Hellman MD, Antonia SJ, Steel NL: Third Line Nivolumab Monotherapy in Recurrent Small Cell Lung Cancer: Checkmate 032. J. Thoracic Oncology, October 10, 2018. PMID: 30316010
Atluri PM, Muzaffar M: Acute Inflammatory Demyelinating Polyradiculoneuropathy Secondary to Ifosfamide. Amer J Ther, July/Aug 2018 (4) PMID: 28816726
Braunstein M, Kucharcyk J, Adams, S: Targeting Toll-Like Receptors For Cancer Therapy. Manuscript accepted for publication in Targeted Oncology . August 2018
Hoang L, Hindenburg A: Utilization rates of enoxaparin and heparin in deep venous thrombosis prophylaxis after Education and Electronic order change at a single Institution: A Quality Improvement Study. Journal of Thrombosis and Thrombolysis. 2018 Nov;46(4):502-506. PMID 30136019
Hoang L, Hindenburg A: Utilization rates of enoxaparin and heparin in venous thromboembolism prophylaxis after education and electronic order change at a single institution: A QI study.
American Society of Oncology abstract 2018. J. Clin Oncol 36, 2018 (suppl; abstr e18836)
Namireddy P, Atluri P, Alwair H, Cahill J, Muzaffar M: Cardiac Metastasis as Initial Site of Recurrence in Rectal Cancer. Am J Med Sci, 2017 Aug. 354 (2) 213-215. PMID 28864381
Janakiram M, Verma A, Wang Y, Budhathoki A, Suarez Londono J, Murakhovskaya I, Braunschweig, Minniti CP : Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease. Leuk Lymphoma 2018 Jan; 59(1) 241-244 Epub 2017 June 7 2017. PMID 28587497
Aditi Shastri, Murali Janakiram, Mantzaris Ioannis, Yiting Yu, Suarez Londono Jaime: Sites of extranodal involvement are prognostic in patients with Stage I follicular lymphoma. Oncotarget 2017 Oct 3; 8(45): 78410-78418, published online 2017 July 14; PMID 29108238
Bannoudi H, Anquetil C, Braunstein M, Pond S, Silverman G. Unbiased RACE-based massive parallel surveys of human IgA antibody repertoires. Methods Mol Biol. 2017;1643:45-73.
Mariampillai AI, DelaCruz JP, Suh Jason, Sivapiragasam A, Nevins K, Hindenburg AA: Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries” J Anticancer Research; Vol 37, Issue No.7 July 2017. PMID 28668856
Suh J, Desai A, Desai A, Cruz JD, Mariampillai A, Hindenburg A. Adherence to thromboprophylaxis guidelines in elderly patients with hospital acquired venous thromboembolism: a case control study.
J Thromb Thrombolysis. 2017 Feb;43(2):172-178. doi: 10.1007/s11239-016-1432-6.
Rohatgi, Abhinav (PGY 5) and Marc Braunstein : Management of atypical chronic CLL presenting with extreme leukocytosis, poster presentation at the 2019 Lymphoma/Myeloma conference, New York, New York
Marks Douglas, Abstract # 585 Impact of RANKL inhibition on tumor microenvironment of early-stage breast cancer, a pre-surgical trial. Accepted for poster presentation at the 2019 San Antonio Breast Symposium Dec. 10-14, 2019.
Marks, Douglas, Akt inhibition associated with change in immunophenotype of tumor microenvironment (TME) in breast cancer (BC) Abstract # 1372, poster presentation at annual San Antonio Breast Cancer Symposium 12/6/18
D’Abreo N, Wronska M, Golbari NM, Sticco K: Case report: Cutaneous Myeloid Sarcoma. Journal Hematology and Multiple Myeloma. Dept Med. Population Health, NYU. Sept. 13, 2018
Hindenburg Alexander, Mariampillai A, DelaCruz J, Abstract acceptance and poster presentation : Evaluation of tumor marker cancer antigen CA72-4 in the monitoring of metastatic or recurent tumors of the GI tract, lung, breast and ovaries, American Society of Clinical Oncology GI Symposium, January 19, 2017, San Francisco California
Braunstein M, El Bannoudi H, Abdul Hay M, Pond S Silverman G: Analysis of the IIgA Heavy Chain Repertoire in Multiple Myeloma: Implications for Host-Microbiome Influences. American Society of Hematology Meeting, poster presentation December 2017
Hindenburg Alexander, Hoang, Linda, Award winning abstract ID # 100149: Comparative Use of direct oral anticoagulants and Warfarin in the treatment of atrial fibrillation and venous thromboembolism and prophylaxis: A retrospective single center utilization study.
Presented at the American Society of Hematology Conference December 2017.
Schneider, Jeffrey, Jain Prantesh, Schalper Kurt, Lovly Christine, Faithlore Gardner, Ross Jeffrey, et al. ERBB Receptor Feedback Inhibitor-1 Alterations in Non-Small cell lung cancer. Abstract accepted and presented at 18th Annual IASLC World Lung Congress, Yokohama Japan Oct.16-19, 2017
Harris, Joshua (PGY 6) 6th Annual John Mordente Lecture NYU Winthrop University Hospital – A Novel Approach to BRCA1 mCRPC with PARP inhibition – receiver of First Prize, $1,000, January 2018
Atluri Prashanti, Harris, Joshua, Hoffman, Jason, Neha Desouza, Y-90 radioembolization comparative outcomes between solid tumor malignancies: a single institution experience . Abstract # e15704, accepted at 2017 ASCO conference
Nina D’Abreo and Douglas Marks: 4th Annual Breast Health Symposium: September 20, 2019, NYU Winthrop Hospital, Mineola, New York
Nina D’Abreo and Douglas Marks: OncoLive State of the Science Summit Breast Cancer. Thurs. Aug 1, 2019 at 5:00pm, Program chairs: Nina D’Abreo and Douglas Marks, Garden City Hotel, Garden City, N.Y. sponsored by NYU Langone
Marc Braunstein: Online media: 6/27/19 NYACP Webinar entitle MedEd 2.0: The Changing World of Medical Education and Why it is important for your career. https://attendee.gotowebinar.com/register/8611014828270967811.
Alexander Hindenburg: Advances in Medicine Grand Rounds, NYU Winthrop Hospital May 29, 2019: “ Full dose unfractionated Heparin Administration: Dose Adjustments using Factor Xassay, no longer with the old PTT”
Michael Garrison: Multi-diagnosis/Multi-disciplinary Cancer Awareness & Education Day November 3, 2018, NYU Winthrop Hospital
Douglas Marks Lecture: Breast cancer in 2018: Strategies for Prevention and Treatment of Breast Cancer, Lunch and Learn, 10/19/18, NYU Winthrop Hospital
Mark Braunstein Lecture: Stem Cell Transplantation, for Palliative Grand Rounds, 11/2/18, NYU Winthrop Hospital
Nina D’Abreo, Lecture: Approaches to Oncologic Care Part I, 7/31/18, Palliative Grand Rounds at NYU Winthrop Hospital
Nina D’Abreo, Lecture: Approaches to Oncologic Care Part II, 8/21/18, Palliative Grand Rounds at NYU Winthrop Hospital
Nina D’Abreo, Lecture: Benign High Risk breast disease , OB-GYN Grand Rounds, NYU Winthrop Hospital 10/26/18
Suarez-Londono, Jaime Andres: Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Past, Present, Future (NYU Winthrop Hospital Medicine Grand rounds 10/18/2017)
Braunstein, Marc: Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Past, Present, Future (NYU Winthrop Hospital Medicine Grand Rounds 10/18/2017)
Hindenburg Alexander, Hon Man, Daggubati Ramesh, Masani Naveed, Nash Alice, Schubach Scott, Rosenthal Barry. DVT-PE, Emergent treatment of pulmonary embolism Part II, NYU*Winthrop Hospital, November 1, 2017.
Book chapter –Pancreatic neoplasms : The role of adjuvant treatment in improving survival. Farhadfar N, Hindenburg A, Harris J, Allendorf J. Accepted for publication 2017
Hindenburg Alexander A: DRG grant completed in 2017: Armo Pancreatic Study, Ammazzalorso research grant, donation for research from private individuals/patients
We continue to be grateful for your thoughtful past contribution in memory of Dr. Michael D. Ammazzalorso, specified for the Dr. Michael D. Ammazzalorso Pancreatic Cancer Research and Education Fund. We are writing to let you know the Fund’s progress and to request your consideration for a renewed contribution. Contributions to the Fund have reached $54,722 from 166 contributors. And, gifts can be made to the Fund at any time, as requests for support from existing and new individual, foundation and corporate contributors are ongoing. The purpose of the Fund is to support pancreatic cancer research and education at NYU Winthrop Hospital, involving patients, residents and medical students. Since the Fund’s inception, your contributions have enabled us to conduct the Dr. Michael D. Ammazzalorso Pancreatic Cancer Research and Education Fund Symposium. And, this year, your support enabled us to seek grant applications to the Fund, resulting in our funding an exciting and meaningful project of an NYU Winthrop Attending Physician who is also an Assistant Professor, Clinical Surgery, Stony Brook School of Medicine. Her impressive proposal for an automated language processing system to convert narrative to discrete data to power pancreatic research captured the Fund Committee’s attention for the impact this will make on unifying our databases for the study of patients with pancreatic cancer, as well as to build upon and advance the field of pancreatic cancer research.
NYU Winthrop Hospital’s graduate medical education programs create an atmosphere in which cultural and ethnic differences among patients, staff, and house staff are recognized, respected, understood and embraced. Residents participate in the care of a diverse group of patients and have the opportunity to work with colleagues from varied backgrounds. NYU Winthrop aims to bring the best residents, fellows and faculty from all ethnic, racial and gender groups to learn and care for patients in this diverse environment.
Housing accommodations, are available at market rates in apartment buildings and residential homes within close proximity to the NYU Winthrop Hospital campus. Any house staff member may apply for the housing lottery. PGY 1 and PGY 2 residents receive priority.
Salaries are highly competitive with other academic medical centers in the New York metropolitan area. Tax deferred annuity is available. House Staff meal stipend will be included in the salary for the 2021-2022 academic year.
2020-2021 Annual Salary
NYU Winthrop Hospital’s new house staff lounge is accessible 24/7. The spacious and comfortable lounge is equipped with computers, wifi, television, foosball table, lockers, lounge chairs, as well as coffee and tea.
NYU Winthrop Hospital residents and fellows receive four weeks of vacation (20 working days) within each contract year.
Residents are eligible for $1500 over the length of their program to attend an educational conference, at the discretion of the Program Director. Fellows are eligible for $1500 per year, to an approved professional conference, at the discretion of the Program Director.
Reimbursement for allowable educational expenses is available up to a maximum of $600.
The TransitChek Commuter Benefit Program is available. This program allows the resident/fellow to deduct pre-tax money to pay for mass transit or commuter parking (up to a predefined maximum).
NYU Winthrop Hospital is committed to providing residents with a comprehensive benefits program. Benefits include generous medical, pharmaceutical and dental coverage, as well as flexible spending accounts. Benefits are effective from the first day of residency/fellowship.
Residents/fellows are covered by short-term, non-occupational disability insurance (up to six months). To be eligible for disability insurance benefits, one must be on the payroll for a minimum of 20 work days (four consecutive weeks) and unable to work for more than seven calendar days, due an injury or illness that does not arise out of, or in the course of, employment. These benefits, which supplement lost income, are based on salary level and are payable for up to 26 weeks after the employee’s accrued sick time has been used.
The long-term disability benefit begins after six months of short term disability. It pays a monthly benefit for an extended illness or injury. The monthly benefit is offset by benefits from other sources, such as Workers Compensation and Social Security.
House staff receive compensation, in accordance with the Workers Compensation Law, for any illness or injury which is job related. Benefits include payment for medical expenses and lost pay.
In accordance with the Family and Medical Leave Act (FMLA) of 1993, NYU Winthrop Hospital will grant residents/fellows unpaid leave(s) for up to 12 weeks in a 12-month period. In order to be eligible, one must have worked 12 months at the Hospital and a minimum of 1,250 hours in the twelve-month period prior to the start date of the requested leave. FMLA leave may be granted for the birth, adoption or acceptance for foster care of a child; for the care of a child, spouse, or parent with a serious health condition; or for the employee’s own serious illness.
Residents/fellows may to return to their training program after a leave of absence, without loss of training status, if their leave does not exceed that allowed by the specialty boards.
NYU Winthrop’s residents/fellows are provided with professional liability coverage for the duration of their training through the Hospital’s self-insurance program. Coverage provides legal defense and protection against awards from claims reported or filed after the completion of graduate medical education if the alleged acts are within the scope of the education program.
Basic Life Insurance is provided by the hospital at no cost to the resident/fellow. This benefit equals 1x the resident/fellow’s annual salary payable to the beneficiary. Residents/fellows may purchase additional voluntary life insurance up to 3X their annual salary (combined basic and voluntary insurance may not exceed $500,000).
Provided by the hospital at no cost to the resident/fellow.
A Defined Contribution 403(b) Plan is available for voluntary pre-tax/after-tax contribution.
NYU Winthrop Hospital residents and fellows are provided with pre-employment physicals, annual health assessments, and Tuberculosis screenings, as well as vaccines and required health surveillance free of charge through the hospital’s Occupational Health Services. In addition, if a member of the house staff becomes ill while at work, he or she will be seen at no charge by an Occupational Health Services practitioner, or by the Emergency Room staff if a practitioner is not available.
Free assessment, referral and brief psychotherapy services are available on a confidential basis to members of the House Staff and their immediate families.
This free, confidential, crisis-response resource is available 24/7 to residents, fellows and their family members to assist with the following concerns –
The longest and largest island in the contiguous United States, Long Island stretches over 100 miles from New York City to Montauk Point. A celebrated summer vacation spot, Long Island offers seasonal beauty, professional sports events, art museums and galleries, and fabulous cuisine. Eastern Long Island has gained fame as for its vineyards, and is home to almost 20 wineries. From NYU Winthrop it is a short trip to Manhattan, where you can enjoy world class dining, museums, and endless cultural opportunities. From scenic Atlantic Ocean beaches to Fire Island, the Hamptons and Montauk Point, Long Island has something for everyone.
Convenient access to NY City is available by Long Island Railroad located directly adjacent to NYU Winthrop Hospital. Residents and fellows take advantage of the opportunity enjoy the myriad of cultural, social, and professional activities in New York City. Additionally, NYU Winthrop’s location in central Nassau County allows easy access to spectacular beaches.
The village of Mineola is a wonderful place to live and work. Mineola affords one the opportunity to enjoy the relaxed Long Island lifestyle, while living only 30 minutes away (via LIRR) from the attractions of NYC.
The close vicinity of the hospital, where most of the resident housing is located, is an excellent location for both families and single residents. Aside from a LIRR station leading directly into NYC, the area is surrounded by a quiet residential neighborhood and a large park with sports facilities, open fields, and a local library. The Roosevelt field mall, one of the largest retail centers on Long Island, is located less than a mile away from the hospital along with a large conglomerate of brand name stores and services.
You can also enjoy the wonderful things that Long Island itself has to offer You will find that living in Mineola is a sound choice from the economic perspective. While residents living in large cities incur significant living expenses, Mineola is very affordable.
ERAS (Electronic residency application system) August of every year.
Residents and fellows can apply for a rotation with any department by contacting the academic coordinator for that program via email with a copy of your CV and the dates you are requesting for your rotation.
The department will review your CV and let you know if there are any rotation spots available for the time requested. If you are approved for the rotation the Office of Academic Affairs will contact you with the necessary paperwork.